KRISTEN SLADE: Open Payments
NPI 1144995242 · CHATSWORTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 19 payments from 7 companies in 2025. Trend: 2023 $343 · 2024 $174 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $218 |
| Lilly USA, LLC | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Medtronic, Inc. | 1 | $17 |
Products named: VRAYLAR, JARDIANCE, GEMTESA, Ohtuvayre, MOUNJARO, CAPLYTA, INCEPTIV, QULIPTA.
Industry payments across GA — which companies pay providers there.
